Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT
Aprea Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -98.26M | -7.94M | -7.76M | -9.45M | -10.25M | -9.67M |
Depreciation & Amortization | 5.43K | 5.43K | 5.43K | 5.43K | 5.3K | 6.16K | 4.99K | 1.43K | 224.00 | 410.00 | -2.38K | 61.37K | 63.69K | 63.77K | 65.99K | 69.44K | 60.24K | 76K |
Stock-Based Compensation | 136.73K | 118.63K | 126.03K | 149.09K | 128.49K | 85.83K | 82.86K | 76.03K | 269.32K | 16.24K | 57.35K | 38.24K | 14.8M | 2.08M | 2.09M | 2.04M | 1.86M | 1.82M |
Other Working Capital | 38.16K | 197.56K | -910.13K | 947.47K | 52.76K | -811.36K | -1.23M | 1.15M | -477.32K | 16.73K | -1.37M | 210.51K | 48.27K | 214.77K | -3.74M | -1.1M | 1.42M | -2.18M |
Other Non-Cash Items | 25.87K | 51.8K | -39.19K | 35.49K | 88.15K | -56.18K | -791.39K | 155.87K | -56.36K | 13.8K | 33.6K | -24.35K | 72.37M | -136.21K | -70.17K | 21.91K | 252.84K | -521.98K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 709.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -59.91K | 125.63K | -708.38K | 1.13M | -290.93K | -1.16M | -425.63K | 882.21K | -170.99K | 1.37M | -1.67M | -2.64M | 2.12M | 429.75K | -4.51M | -908.99K | 322.55K | -3.23M |
Operating Cash Flow | -3.13M | -3.63M | -3.51M | -2.47M | -3.54M | -3.94M | -3.86M | -2.09M | -3.22M | -2.98M | -4.02M | -6.59M | -8.9M | -5.5M | -10.18M | -8.23M | -7.75M | -11.52M |
Capital Expenditures | n/a | n/a | 380.49 | -209 | -7.29K | -7.98K | -8.56K | -84.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 384.41 | -209 | -7.29K | -7.98K | -8.56K | -84.08K | 24.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -22.92K | n/a | -6.35K | -280.84K | n/a | -1.29M | n/a | n/a | -24.84K | -648.93K | n/a | n/a | n/a | n/a | 1.66M | 86.97K | n/a | n/a |
Financial Cash Flow | 384.88K | 55.85K | 134.41K | -1.16K | -219.92K | 14.71M | 86.38K | -86.59K | -24.84K | 5.14M | 98.53K | 584.45K | n/a | n/a | 1.66M | 86.97K | n/a | n/a |
Net Cash Flow | -2.74M | -3.57M | -3.4M | -2.44M | -3.68M | 10.76M | -3.75M | -2.33M | -3.27M | 2.21M | -4.33M | -5.95M | -8.59M | -5.42M | -8.35M | -8.38M | -7.81M | -11.4M |
Free Cash Flow | -3.13M | -3.63M | -3.51M | -2.47M | -3.55M | -3.94M | -3.87M | -2.33M | -3.22M | -2.98M | -4.02M | -6.59M | -8.9M | -5.5M | -10.18M | -8.23M | -7.75M | -11.52M |